The Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) is committed to developing concrete, actionable, consensus-driven ethics guidance on how to equitably include the interests of pregnant women and their offspring in vaccine R&D for priority pathogens and emerging epidemic threats. The multi-disciplinary approach brings together a team of scholars and scientists with expertise in bioethics, maternal immunization, maternal-fetal medicine, obstetrics, pediatrics, philosophy, public health, and vaccine research.
You can download the PREVENT report on the subject of inclusion of pregnant women in vaccine trials in emergencies here. The authors make multiple recommendations to funders, industry as well as academia which may be of great interest to many of you.
Our IMPRINT executive board member and challenge 5 co-lead Sonali Kochhar is part of the working team and co-authored the report.
PREVENT is a grant-funded project led by faculty at Johns Hopkins University alongside co-investigators at Georgetown University and the University of North Carolina at Chapel Hill, with external contributions from Working Group Members. The PREVENT Project is funded by the Wellcome Trust.
Dr Chris Gale from Imperial College London provided new insights about the impact of COVID-19 on the health of neonates in a webinar organised by IMPRINT.